CD8A and neoplasm: When performed in conjunction with CTLA-4 blockade, Cryo improved survival in a TRAMP C2 mouse model of prostate cancer, also generating intratumoral and systemic expansion of CD8+ T cells against the SPAS-1 tumor-specific antigen (19).